Document Detail


Rapamycin inhibits activator protein-1 but not nuclear factor-kappaB activity of mature bone marrow-derived dendritic cells.
MedLine Citation:
PMID:  20620542     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Rapamycin (Rapa), a recently introduced immunosuppressive drug, appears to be effective in preventing acute allograft rejection episodes. Its effects on differentiation and maturation of dendritic cells (DCs) have been studied. In this report, we evaluated the effects of Rapa on the intracellular signal transduction pathways in mature DCs. The results showed that Rapa did not depress p65, p50, or IkappaBalpha expression. However, it dramatically reduced activator protein-1 activation. The fact that Rapa exerts a specific effect on activator protein-1 activity in mature DCs may contribute to its unique actions to prevent allograft rejection and induce immune tolerance.
Authors:
G-Y Wang; G-H Chen; H Li; Y Huang; J Zhang; N Jiang; W-J Chen
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Transplantation proceedings     Volume:  42     ISSN:  1873-2623     ISO Abbreviation:  Transplant. Proc.     Publication Date:  2010 Jun 
Date Detail:
Created Date:  2010-07-12     Completed Date:  2010-10-29     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0243532     Medline TA:  Transplant Proc     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1881-3     Citation Subset:  IM    
Affiliation:
Liver Transplantation Institution, the Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, Guangdong Province, China.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Actins / genetics
Animals
Bone Marrow Cells / cytology*,  drug effects
Cell Nucleus / drug effects,  physiology
Dendritic Cells / cytology,  drug effects,  physiology*
NF-kappa B / drug effects,  genetics,  physiology*
Rats
Rats, Inbred Lew
Reverse Transcriptase Polymerase Chain Reaction
Sirolimus / pharmacology*
Transcription Factor AP-1 / drug effects*,  metabolism
Chemical
Reg. No./Substance:
0/Actins; 0/NF-kappa B; 0/Transcription Factor AP-1; 53123-88-9/Sirolimus

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Urinary connective tissue growth factor is a biomarker in a rat model of chronic nephropathy.
Next Document:  The changes of aquaporin 2 in the graft of acute rejection rat renal transplantation model.